IR-Med Inc.
IRME - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$204.49K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $204,493.00 |
|---|---|
| Enterprise Value | $564,493.00 |
| Earnings per Share | $-0.03 |
| Beta | 0.71 |
| Outstanding Shares | 73,755,083 |
Return
| Return on Equity | 376.00% |
|---|---|
| Return on Assets | -1342.86% |
| Return on Invested Capital | 236.39% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | -0.09 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 21.71 |
| Enterprise Value to EBIT | -0.4 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.75 |
| Debt to Equity | -0.68 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About IR-Med Inc.
3 employees
CEO: Yaniv Cohen
IR-Med Inc. is an emerging medical technology firm dedicated to developing advanced diagnostic and medical solutions by leveraging a platform that integrates infra-red light spectroscopy with artificial intelligence. The company's produc...